BackgroundDrug-induced gingival overgrowth (DIGO) as an interdisciplinary clinical challenge, faces dual therapeutic barriers due to its unclear pathogenesis and high recurrence rate, forcing clinicia

NIAID Data Ecosystem00

Safety outcomes in the patients who received an injection of the investigational product.

临床试验安全性评估

药物不良反应监测

Safety outcomes in the patients who received an injection of the investigational product.

Figshare2019-12-10 更新50

Table 1_Safety of individualized herbal medicine for dysmenorrhea: pharmacovigilance from South Korea’s national pilot.docx

药物警戒

痛经草药安全性

BackgroundIn 2020, South Korea’s National Health Insurance (NHI) began reimbursing individually prescribed herbal medicine decoctions (HMDs) for dysmenorrhea, highlighting the need for robust post-cov

NIAID Data Ecosystem00